Related Experiment Video

Updated: Aug 6, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy

David R Berk1, Susan Bayliss Mallory, Emmet B Keeffe

  • 1Division of Dermatology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|August 22, 2006
PubMed

Insights

Chronic hepatitis C virus (HCV) infection can cause skin conditions. Data on how interferon therapy affects these extrahepatic manifestations in HCV patients is limited and shows variable responses.

Area of Science:

  • Hepatology and Dermatology
  • Virology and Immunology

Background:

  • Chronic hepatitis C virus (HCV) infection is linked to various extrahepatic manifestations, notably dermatologic conditions like mixed cryoglobulinemia, porphyria cutanea tarda, and lichen planus.
  • Patients with chronic HCV and these extrahepatic manifestations are frequently excluded from clinical trials of interferon (IFN) therapy due to concerns about efficacy and safety.

Purpose of the Study:

  • To review existing data on dermatologic conditions associated with chronic HCV infection.
  • To summarize the efficacy of interferon (IFN) therapy on these extrahepatic manifestations in HCV patients.

Main Methods:

  • Systematic review of published literature and case reports.
  • Analysis of data concerning dermatologic manifestations in chronic HCV patients treated with IFN therapy.

Main Results:

  • Limited data exists on the efficacy of IFN therapy for extrahepatic manifestations in chronic HCV patients.
  • Case reports indicate a highly variable response of dermatologic conditions to IFN treatment in this patient population.

Conclusions:

  • The effectiveness of interferon therapy for treating dermatologic extrahepatic manifestations in chronic hepatitis C virus infection is not well-established.
  • Further research is needed to clarify the role and outcomes of IFN therapy in managing these associated skin conditions.

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...